Friday, 30 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US

Medical Device

  • Company
  • Drug
  • Deals
  • Policy / Regulatory
  • Medical Device
  • R&D
  • Digital
  • Legal / IP
  • Others
  • Hospital
  • General/Other
Lifetech's ICS Elpis Bioresorbable Peripheral Stent Enters NMPA Green Channel – World's First Fully Bioresorbable Covered Stent System for Iliac Artery Disease
HKG: 1302Lifetech Scientific

Lifetech’s ICS Elpis Bioresorbable Peripheral Stent Enters NMPA Green Channel – World’s First Fully Bioresorbable Covered Stent System for Iliac Artery Disease

Lifetech Scientific Corporation (HKG: 1302) announced that the ICS Elpis Bioresorbable Peripheral Balloon‑Expandable Covered Stent System, independently developed by its subsidiary Yuanxin Technology (Shenzhen) Co., Ltd., was approved for entry…

October 21, 2026
GE HealthCare Launches Global Clinical Evaluation of StarGuide GXi – Next‑Generation Digital 4D SPECT/CT Spans Three Continents and Five Elite Institutions

GE HealthCare Launches Global Clinical Evaluation of StarGuide GXi – Next‑Generation Digital 4D SPECT/CT Spans Three Continents and Five Elite Institutions

October 21, 2026
Sansure Biotech's Quadruplex Respiratory Pathogen PCR Kit Wins NMPA Registration – Second Lyophilized Four‑in‑One Test Extends AI‑Driven Respiratory Panel Portfolio to Eight Pathogens

Sansure Biotech’s Quadruplex Respiratory Pathogen PCR Kit Wins NMPA Registration – Second Lyophilized Four‑in‑One Test Extends AI‑Driven Respiratory Panel Portfolio to Eight Pathogens

October 13, 2026

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
HKG: 2252Market launch

Shanghai MicroPort MedBot Completes World’s Furthest Remote Robot Surgery via 5G

March 27, 2025

Shanghai Roche Pharmaceuticals Launches Erlotinib for Advanced Non-Small Cell Lung Cancer in China

November 23, 2024
Show More
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up